A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash

This study has been terminated.

( Lack of enrollment )

Study NCT00343187 Information provided by Allergan

First Received: June 20, 2006 Last Updated: September 8, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	July 2007
Estimated Primary Completion Date:	No date given